Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.
Kaemmerer H, Gorenflo M, Huscher D, Pittrow D, Apitz C, Baumgartner H, Berger F, Bruch L, Brunnemer E, Budts W, Claussen M, Coghlan G, Dähnert I, D'Alto M, Delcroix M, Distler O, Dittrich S, Dumitrescu D, Ewert R, Faehling M, Germund I, Ghofrani HA, Grohé C, Grossekreymborg K, Halank M, Hansmann G, Harzheim D, Nemes A, Havasi K, Held M, Hoeper MM, Hofbeck M, Hohenfrost-Schmidt W, Jurevičienė E, Gumbienè L, Kabitz HJ, Klose H, Köhler T, Konstantinides S, Köestenberger M, Kozlik-Feldmann R, Kramer HH, Kropf-Sanchen C, Lammers A, Lange T, Meyn P, Miera O, Milger-Kneidinger K, Neidenbach R, Neurohr C, Opitz C, Perings C, Remppis BA, Riemekasten G, Scelsi L, Scholtz W, Simkova I, Skowasch D, Skride A, Stähler G, Stiller B, Tsangaris I, Vizza CD, Vonk Noordegraaf A, Wilkens H, Wirtz H, Diller GP, Grünig E, Rosenkranz S. Kaemmerer H, et al. Among authors: rosenkranz s. J Clin Med. 2020 May 13;9(5):1456. doi: 10.3390/jcm9051456. J Clin Med. 2020. PMID: 32414075 Free PMC article.
[PDE5 inhibitors in the treatment of pulmonary hypertension].
Dumitrescu D, Erdmann E, Rosenkranz S. Dumitrescu D, et al. Among authors: rosenkranz s. Pharm Unserer Zeit. 2010 Sep;39(5):391-6. doi: 10.1002/pauz.201000385. Pharm Unserer Zeit. 2010. PMID: 20818689 Review. German. No abstract available.
Imatinib mesylate for the treatment of pulmonary arterial hypertension.
ten Freyhaus H, Dumitrescu D, Berghausen E, Vantler M, Caglayan E, Rosenkranz S. ten Freyhaus H, et al. Among authors: rosenkranz s. Expert Opin Investig Drugs. 2012 Jan;21(1):119-34. doi: 10.1517/13543784.2012.632408. Epub 2011 Nov 11. Expert Opin Investig Drugs. 2012. PMID: 22074410 Review.
Pulmonary hypertension due to left heart disease: updated Recommendations of the Cologne Consensus Conference 2011.
Rosenkranz S, Bonderman D, Buerke M, Felgendreher R, ten Freyhaus H, Grünig E, de Haan F, Hammerstingl C, Harreuter A, Hohenforst-Schmidt W, Kindermann I, Kindermann M, Kleber FX, Kuckeland M, Kuebler WM, Mertens D, Mitrovic V, Opitz C, Schmeisser A, Schulz U, Speich R, Zeh W, Weil J. Rosenkranz S, et al. Int J Cardiol. 2011 Dec;154 Suppl 1:S34-44. doi: 10.1016/S0167-5273(11)70491-0. Int J Cardiol. 2011. PMID: 22221972
Chronic thromboembolic pulmonary hypertension (CTEPH): updated Recommendations of the Cologne Consensus Conference 2011.
Wilkens H, Lang I, Behr J, Berghaus T, Grohe C, Guth S, Hoeper MM, Kramm T, Krüger U, Langer F, Rosenkranz S, Schäfers HJ, Schmidt M, Seyfarth HJ, Wahlers T, Worth H, Mayer E. Wilkens H, et al. Among authors: rosenkranz s. Int J Cardiol. 2011 Dec;154 Suppl 1:S54-60. doi: 10.1016/S0167-5273(11)70493-4. Int J Cardiol. 2011. PMID: 22221974 Free article.
Safety and efficacy of exercise training in various forms of pulmonary hypertension.
Grünig E, Lichtblau M, Ehlken N, Ghofrani HA, Reichenberger F, Staehler G, Halank M, Fischer C, Seyfarth HJ, Klose H, Meyer A, Sorichter S, Wilkens H, Rosenkranz S, Opitz C, Leuchte H, Karger G, Speich R, Nagel C. Grünig E, et al. Among authors: rosenkranz s. Eur Respir J. 2012 Jul;40(1):84-92. doi: 10.1183/09031936.00123711. Epub 2012 Feb 9. Eur Respir J. 2012. PMID: 22323570 Free article.
Clinical impact of atrial fibrillation in patients with pulmonary hypertension.
Rottlaender D, Motloch LJ, Schmidt D, Reda S, Larbig R, Wolny M, Dumitrescu D, Rosenkranz S, Erdmann E, Hoppe UC. Rottlaender D, et al. Among authors: rosenkranz s. PLoS One. 2012;7(3):e33902. doi: 10.1371/journal.pone.0033902. Epub 2012 Mar 16. PLoS One. 2012. PMID: 22439013 Free PMC article.
Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension.
Nagel C, Prange F, Guth S, Herb J, Ehlken N, Fischer C, Reichenberger F, Rosenkranz S, Seyfarth HJ, Mayer E, Halank M, Grünig E. Nagel C, et al. Among authors: rosenkranz s. PLoS One. 2012;7(7):e41603. doi: 10.1371/journal.pone.0041603. Epub 2012 Jul 25. PLoS One. 2012. PMID: 22848542 Free PMC article. Clinical Trial.
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.
Hoeper MM, Huscher D, Ghofrani HA, Delcroix M, Distler O, Schweiger C, Grunig E, Staehler G, Rosenkranz S, Halank M, Held M, Grohé C, Lange TJ, Behr J, Klose H, Wilkens H, Filusch A, Germann M, Ewert R, Seyfarth HJ, Olsson KM, Opitz CF, Gaine SP, Vizza CD, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Pittrow D. Hoeper MM, et al. Among authors: rosenkranz s. Int J Cardiol. 2013 Sep 30;168(2):871-80. doi: 10.1016/j.ijcard.2012.10.026. Epub 2012 Nov 17. Int J Cardiol. 2013. PMID: 23164592
619 results